SCHEMBL7733979

SCHEMBL7733979

C=C(C)C1C[C@@H](C(=O)OCC)N(C(=O)OC(C)(C)C)C1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
TSHR P16473 3/20 0.37
ALDH1A1 P00352 1/20 0.37
FKBP1A P62942 2/20 0.36
NR1H2 P55055 1/20 0.35
CYP1A2 P05177 1/20 0.35
POLB P06746 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C19 P33261 1/20 0.35
ALOX15 P16050 1/20 0.34
MAPK1 P28482 1/20 0.34
MAPT P10636 1/20 0.34
HSD17B10 Q99714 1/20 0.33
NFKB1 P19838 1/20 0.33
NFKB2 Q00653 1/20 0.33
RELA Q04206 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.32
CTSL P07711 1/20 0.32
CTSB P07858 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7730850 0.82 HSD17B10 (0.42) TSHRNR1H2CYP1A2POLBCYP3A4
SCHEMBL24023405 0.82 MEN1 (0.41) MEN1KMT2ATSHRALDH1A1FKBP1A
SCHEMBL24023379 0.82 MEN1 (0.41) MEN1KMT2ATSHRALDH1A1FKBP1A
SCHEMBL7728453 0.81 FKBP1A (0.39) MEN1KMT2ATSHRALDH1A1FKBP1A
SCHEMBL117368 0.81 CYP1A2 (0.40) MEN1KMT2ATSHRALDH1A1FKBP1A
SCHEMBL7811172 0.81 CYP1A2 (0.40) MEN1KMT2ATSHRALDH1A1FKBP1A
SCHEMBL8256266 0.81 CYP1A2 (0.40) MEN1KMT2ATSHRALDH1A1FKBP1A
SCHEMBL9635522 0.81 POLB (0.50) MEN1KMT2ATSHRALDH1A1FKBP1A
SCHEMBL116396 0.81 POLB (0.50) MEN1KMT2ATSHRALDH1A1FKBP1A
SCHEMBL9731413 0.81 FKBP1A (0.39) MEN1KMT2ATSHRALDH1A1FKBP1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6399629-B1 PYRROLIDINES AND PIPERIDINES FOR TREATING MICROBIAL INFECTIONS BY REDUCING EXPORT OF COADMINISTERED ANTIMICROBIAL AGENT OR COMPOUND SYNTHESIZED BY MICROBES FOR THEIR GROWTH; REDUCING IN VIVO AVAILABILITY MICROCIDE PHARMACEUTICALS, INC. 2002-06-04 US disclosed
WO-2000001714-A1 EFFLUX PUMP INHIBITORS MICROCIDE PHARMACEUTICALS, INC. (US) 2000-01-13 WO disclosed